Vitalibis, Inc. (VCBD)
OTCMKTS · Delayed Price · Currency is USD
0.0013
-0.0002 (-13.33%)
At close: Jul 30, 2025
Vitalibis Market Cap
Vitalibis has a market cap or net worth of $591.85 thousand as of August 1, 2025. Its market cap has increased by 2,109.46% in one year.
Market Cap
591.85K
Enterprise Value
n/a
Revenue
243.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 22, 2018, Vitalibis's market cap has decreased from 40.52M to 591.85K, a decrease of -98.54%. That is a compound annual growth rate of -43.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 591.85K | 1,611.19% |
| Dec 31, 2024 | 34.59K | -50.00% |
| Dec 27, 2023 | 69.17K | - |
| Dec 30, 2022 | 69.17K | 29.12% |
| Dec 31, 2021 | 53.57K | -87.54% |
| Dec 31, 2020 | 429.82K | -93.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |